Markopoulou, Kalypso

Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system

Carvalho, L. A., Torre, J. P., Papadopoulos, A. S., Poon, L., Juruena, M. F., Markopoulou, K., Cleare, A. J., & Pariante, C. M. (2013) · Journal of Affective Disorders

Tryptophan and brain disordersTreatment of Major Depression

Cited by 167

The Maudsley Staging Method for Treatment-Resistant Depression: Prediction of Longer-Term Outcome and Persistence of Symptoms

Fekadu, A., Wooderson, S. C., Markopoulou, K., & Cleare, A. J. (2009) · The Journal of Clinical Psychiatry

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 125

Prediction of longer-term outcome of treatment-resistant depression in tertiary care

Fekadu, A., Rane, L. J., Wooderson, S. C., Markopoulou, K., Poon, L., & Cleare, A. J. (2012) · British Journal of Psychiatry

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 77

Longitudinal course of symptom severity and fluctuation in patients with treatment-resistant unipolar and bipolar depression

Vergunst, F. K., Fekadu, A., Wooderson, S. C., Tunnard, C. S., Rane, L. J., Markopoulou, K., & Cleare, A. J. (2013) · Psychiatry Research

Treatment of Major DepressionBipolar Disorder and Treatment

Cited by 45

Long-Term Impact of Residual Symptoms in Treatment-Resistant Depression

Fekadu, A., Wooderson, S. C., Rane, L. J., Markopoulou, K., Poon, L., & Cleare, A. J. (2011) · The Canadian Journal of Psychiatry

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 23

Long-term symptomatic and functional outcome following an intensive inpatient multidisciplinary intervention for treatment-resistant affective disorders

Wooderson, S. C., Fekadu, A., Markopoulou, K., Rane, L. J., Poon, L., Juruena, M. F., Strawbridge, R., & Cleare, A. J. (2014) · Journal of Affective Disorders

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 22